CoChat

Melanoma models for the next generation of therapies

Open access
Patton, E. Elizabeth, Mueller, Kristen L., Adams, David J., Anandasabapathy, Niroshana, Aplin, Andrew E., Bertolotto, Corine, Bosenberg, Marcus, Ceol, Craig J., Burd, Christin E., Chi, Ping, Herlyn, Meenhard, Holmen, Sheri L., Karreth, Florian A., Kaufman, Charles K., Khan, Shaheen, Kobold, Sebastian, Leucci, Eleonora, Levy, Carmit, Lombard, David B., Lund, Amanda W., Marie, Kerrie L., Marine, Jean-Christophe, Marais, Richard, McMahon, Martin, Robles-Espinoza, Carla Daniela, Ronai, Ze'ev A., Samuels, Yardena, Soengas, Maria S., Villanueva, Jessie, Weeraratna, Ashani T., White, Richard M., Yeh, Iwei, Zhu, Jiyue, Zon, Leonard I., Hurlbert, Marc S., Merlino, Glenn · 2021 · Cancer Cell
Cited by 206

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Abstract

SUMMARY There is a lack of appropriate melanoma models that can be used to evaluate the efficacy of novel therapeutic modalities. Here, we discuss the current state of the art of melanoma models including genetically engineered mouse, patient-derived xenograft, zebrafish, and ex vivo and in vitro models. We also identify five major challenges that can be addressed using such models, including metastasis and tumor dormancy, drug resistance, the melanoma immune response, and the impact of aging and environmental exposures on melanoma progression and drug resistance. Additionally, we discuss the opportunity for building models for rare subtypes of melanomas, which represent an unmet critical need. Finally, we identify key recommendations for melanoma models that may improve accuracy of preclinical testing and predict efficacy in clinical trials, to help usher in the next generation of melanoma therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2021.01.011

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 206

Metadata

Authors
Patton, E. E., Mueller, K. L., Adams, D. J., Anandasabapathy, N., Aplin, A. E., Bertolotto, C., Bosenberg, M., Ceol, C. J., Burd, C. E., Chi, P., Herlyn, M., Holmen, S. L., Karreth, F. A., Kaufman, C. K., Khan, S., Kobold, S., Leucci, E., Levy, C., Lombard, D. B., Lund, A. W., Marie, K. L., Marine, J.-C., Marais, R., McMahon, M., Robles-Espinoza, C. D., Ronai, Z. A., Samuels, Y., Soengas, M. S., Villanueva, J., Weeraratna, A. T., White, R. M., Yeh, I., Zhu, J., Zon, L. I., Hurlbert, M. S., & Merlino, G.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2021-05
Volume
39
Issue
5
Pages
610-631
ISSN
1535-6108 (ISSN-L)
OpenAlex
W3128442055
Cited by
206
References
64
FWCI
10.80
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Melanoma models for the next generation of therapies. https://app.cochat.ai/papers/10.1016/j.ccell.2021.01.011
The paper
Patton, E. E., Mueller, K. L., Adams, D. J., Anandasabapathy, N., Aplin, A. E., Bertolotto, C., Bosenberg, M., Ceol, C. J., Burd, C. E., Chi, P., Herlyn, M., Holmen, S. L., Karreth, F. A., Kaufman, C. K., Khan, S., Kobold, S., Leucci, E., Levy, C., Lombard, D. B., . . . Merlino, G. (2021). Melanoma models for the next generation of therapies. Cancer Cell. https://doi.org/10.1016/j.ccell.2021.01.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.